Sera Prognostics, Inc. Class A SERA

NASDAQHealth ServicesUnited States

$2.01+0.03 (+1.52%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 1.952.04
52-week range: 1.563.85

Financial health

– / 5

Analyst view · 4 firms

Buy4 buy · 0 hold · 0 sell

Avg. target $5.50 (+173.6%)

Prices may be delayed and are for informational purposes only - not investment advice.

Sera Prognostics, Inc. Class A SERA

NASDAQHealth ServicesUnited States

$2.01+0.03 (+1.52%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 1.952.04
52-week range: 1.563.85

Financial health

– / 5

Analyst view · 4 firms

Buy4 buy · 0 hold · 0 sell

Avg. target $5.50 (+173.6%)

Valuation from filings

Calculated from the tables below and the current price ($2.01) · LTM · 2026/9 · 2026-09-30

P/E: —EPS $-0.67
P/B: 1.94BV/share $1.04
P/S: 1,057.52Sales/share $0.00
Return on equity: -63.8%Net income / equity
Net margin: -34,866.7%Operating margin -38,755.2%
Free cash flow yield: -36.3%Free cash flow / market cap

Revenue and net income

Fiscal year · $ millions · net margin below

RevenueNet Income

Financial statements

$ thousands · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	82	268+227%	306+14%	77-75%	81+5%	96
Cost of Revenue
Gross Profit
Operating expenses
Operating Income
EBITDA
Pre-tax income
Income tax (expense) / benefit
Net Income	(35,009)	(44,186)+26%	(36,242)-18%	(32,898)-9%	(31,928)-3%	(33,472)
Earnings per share ($)
Margins
Gross margin
Operating margin
EBITDA margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.